These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 22072121

  • 1. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B, Florence C, Kamel R, Nadia K, Ines O, Raja M, Sarra BJ, Florent S, Amel BA.
    Cancer Biomark; ; 8(6):331-40. PubMed ID: 22072121
    [Abstract] [Full Text] [Related]

  • 2. Mutation analysis of BRAF exon 15 and KRAS codons 12 and 13 in Moroccan patients with colorectal cancer.
    Bennani B, Gilles S, Fina F, Nanni I, Ibrahimi SA, Riffi AA, Nejjari C, Benajeh DA, El Abkari M, Martin PM, Ouafik L.
    Int J Biol Markers; 2010; 25(4):179-84. PubMed ID: 21161938
    [Abstract] [Full Text] [Related]

  • 3. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC.
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing.
    Borràs E, Jurado I, Hernan I, Gamundi MJ, Dias M, Martí I, Mañé B, Arcusa A, Agúndez JA, Blanca M, Carballo M.
    BMC Cancer; 2011 Sep 24; 11():406. PubMed ID: 21943394
    [Abstract] [Full Text] [Related]

  • 5. Frequency of KRAS, BRAF, and PIK3CA mutations in advanced colorectal cancers: Comparison of peptide nucleic acid-mediated PCR clamping and direct sequencing in formalin-fixed, paraffin-embedded tissue.
    Kwon MJ, Lee SE, Kang SY, Choi YL.
    Pathol Res Pract; 2011 Dec 15; 207(12):762-8. PubMed ID: 22070922
    [Abstract] [Full Text] [Related]

  • 6. High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples.
    De Miglio MR, Mura A, Uras MG, Manca A, Contini M, Murgia L, Zinellu A, Sotgia S, Carru C, Massarelli G, Cossu-Rocca P.
    Diagn Mol Pathol; 2010 Dec 15; 19(4):201-8. PubMed ID: 21052001
    [Abstract] [Full Text] [Related]

  • 7. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.
    Simi L, Pratesi N, Vignoli M, Sestini R, Cianchi F, Valanzano R, Nobili S, Mini E, Pazzagli M, Orlando C.
    Am J Clin Pathol; 2008 Aug 15; 130(2):247-53. PubMed ID: 18628094
    [Abstract] [Full Text] [Related]

  • 8. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis.
    Fassina A, Gazziero A, Zardo D, Corradin M, Aldighieri E, Rossi GP.
    J Clin Pathol; 2009 Dec 15; 62(12):1096-102. PubMed ID: 19640859
    [Abstract] [Full Text] [Related]

  • 9. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M.
    Gut; 2009 Sep 15; 58(9):1234-41. PubMed ID: 19474002
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
    Chang YS, Er TK, Lu HC, Yeh KT, Chang JG.
    Clin Chim Acta; 2014 Sep 25; 436():169-75. PubMed ID: 24863805
    [Abstract] [Full Text] [Related]

  • 12. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L.
    Magy Onkol; 2010 Dec 25; 54(4):383-94. PubMed ID: 21163770
    [Abstract] [Full Text] [Related]

  • 13. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
    Neumann J, Zeindl-Eberhart E, Kirchner T, Jung A.
    Pathol Res Pract; 2009 Dec 25; 205(12):858-62. PubMed ID: 19679400
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.
    Ibrahem S, Seth R, O'Sullivan B, Fadhil W, Taniere P, Ilyas M.
    Int J Exp Pathol; 2010 Dec 25; 91(6):500-5. PubMed ID: 21199003
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
    Perez K, Walsh R, Brilliant K, Noble L, Yakirevich E, Breese V, Jackson C, Chatterjee D, Pricolo V, Roth L, Shah N, Cataldo T, Safran H, Hixson D, Quesenberry P.
    Exp Mol Pathol; 2013 Aug 25; 95(1):74-82. PubMed ID: 23528430
    [Abstract] [Full Text] [Related]

  • 18. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mohamed Suhaimi NA, Foong YM, Lee DY, Phyo WM, Cima I, Lee EX, Goh WL, Lim WY, Chia KS, Kong SL, Gong M, Lim B, Hillmer AM, Koh PK, Ying JY, Tan MH.
    Mol Oncol; 2015 Apr 25; 9(4):850-60. PubMed ID: 25605225
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP, de Melo FM, Lisboa BC, Andrade LD, de Souza Begnami MD, Junior SA, Ribeiro HS, Soares FA, Carraro DM, da Cunha IW.
    Exp Mol Pathol; 2015 Jun 25; 98(3):563-7. PubMed ID: 25835782
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.